CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC)

Historical Holders from Q1 2019 to Q3 2025

Symbol
CVAC on Nasdaq
Type / Class
Equity / Common Shares, par value (euro)0.12 per share
Shares outstanding
22,421,536
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
19,565,943
Holdings value
$105,427,908
% of all portfolios
0%
Number of holders
92
Number of buys
38
Number of sells
-38
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 19,565,943 $105,427,908 +$42,943,166 $5.39 92
2025 Q2 11,518,381 $62,488,985 +$21,426,773 $5.43 88
2025 Q1 7,872,317 $21,841,913 -$777,543 $2.77 81
2024 Q4 7,855,201 $26,621,771 -$5,836,624 $3.41 74
2024 Q3 11,129,364 $32,809,500 -$7,039,565 $2.94 78
2024 Q2 14,229,273 $48,278,571 -$9,342,638 $3.4 85
2024 Q1 15,940,182 $48,278,751 -$19,660,440 $3.03 88
2023 Q4 22,199,014 $93,446,194 -$57,799,701 $4.21 88
2023 Q3 33,716,537 $230,128,246 -$14,892,714 $6.83 84
2023 Q2 35,746,141 $372,596,379 -$7,716,451 $10.42 86
2023 Q1 36,701,197 $255,777,503 +$175,104,339 $6.97 81
2022 Q4 11,606,048 $70,002,654 +$26,244,613 $6.03 79
2022 Q3 7,148,145 $56,407,292 -$15,368,475 $7.88 76
2022 Q2 8,406,419 $114,404,583 -$92,528,445 $13.61 79
2022 Q1 14,444,471 $283,158,200 -$10,020,593 $19.61 103
2021 Q4 14,649,709 $503,022,059 +$22,422,488 $34.31 99
2021 Q3 13,728,835 $749,897,430 -$11,662,295 $54.62 104
2021 Q2 10,743,822 $789,319,360 -$28,307,983 $73.48 104
2021 Q1 14,053,252 $1,284,956,347 +$337,575,946 $91.46 83
2020 Q4 7,249,066 $588,215,271 -$18,687,692 $81.07 58
2020 Q3 7,605,083 $355,419,000 +$354,563,000 $46.55 42
2020 Q2 108 $8,000 $74.07 1
2020 Q1 108 $8,000 $74.07 1
2019 Q4 108 $8,000 $74.07 1
2019 Q3 108 $8,000 $74.07 1
2019 Q2 108 $8,000 $74.07 1
2019 Q1 108 $8,000 $74.07 1